INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION

被引：0
|
作者：
DUTCHER, JP [1 ]
WIERNIK, PH [1 ]
TODD, M [1 ]
CALIENDO, G [1 ]
BENSON, L [1 ]
机构：
[1] ALBERT EINSTEIN CANC CTR,NEW YORK,NY
来源：
EXPERIMENTAL HEMATOLOGY | 1993年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1048 / 1048
页数：1
相关论文
共 50 条
  • [21] Induction of Tissue Factor by Interleukin-2 in Acute Myelogenous Leukemia (AML) Cells
    Tanaka, Masao
    Kishi, Tatsuo
    [J]. GROWTH FACTORS, 1990, 4 (01) : 1 - 8
  • [22] Children's Cancer Group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia
    Sievers, EL
    Lange, BJ
    Sondel, PM
    Krailo, MD
    Gan, J
    Tjoa, T
    Mares, WL
    Feig, SA
    [J]. CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 2000, 6 : S39 - S44
  • [23] INTERLEUKIN-2 MAY INDUCE PROLONGED REMISSIONS IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA
    MELONI, G
    FOA, R
    VIGNETTI, M
    GUARINI, A
    FENU, S
    TOSTI, S
    TOS, AG
    MANDELLI, F
    [J]. BLOOD, 1994, 84 (07) : 2158 - 2163
  • [24] BAVC CONDITIONING REGIMEN AND ABMT IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR)
    MELONI, G
    DEFABRITIIS, P
    PULSONI, A
    GIARNIERI, V
    PETTI, MC
    AMADORI, S
    MANDELLI, F
    [J]. BONE MARROW TRANSPLANTATION, 1988, 3 : 72 - 72
  • [25] BAVC REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION
    MELONI, G
    DEFABRITIIS, P
    PETTI, MC
    MANDELLI, F
    [J]. BLOOD, 1990, 75 (12) : 2282 - 2285
  • [26] A UNIQUE CASE OF 3 AUTOGRAFTS FOR ACUTE MYELOGENOUS LEUKEMIA WITH SUBSEQUENT LONG-TERM SURVIVAL IN 2ND REMISSION
    LIM, SH
    MCMILLAN, AK
    GRIBBEN, J
    GALVIN, MC
    GOLDSTONE, AH
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 207 - 209
  • [27] ACTIVE IMMUNOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA AND INDUCTION OF 2ND AND SUBSEQUENT REMISSIONS
    HARRIS, R
    ZUHRIE, SR
    FREEMAN, CB
    TAYLOR, GM
    MACIVER, JE
    GEARY, CG
    DELAMORE, IW
    HULL, PJ
    TOOTH, JA
    [J]. BRITISH JOURNAL OF CANCER, 1978, 37 (02) : 282 - 288
  • [28] Interleukin 2 (IL2) therapy for adult patients (pts) with acute myelogenous leukemia (AML) in first complete remission (CR).
    Cortes, J
    Kantarjian, H
    OBrien, S
    Keating, M
    Estey, E
    [J]. BLOOD, 1997, 90 (10) : 2252 - 2252
  • [29] Induction remission for refractory acute lymphoblastic leukemia: Role of interleukin-2 priming chemotherapy
    Zhang, C.
    Chen, X. -H.
    Yang, S. -J.
    Luo, X. -Q.
    Liu, Y.
    Gao, L.
    Gao, L.
    Wang, P.
    Kong, P. -Y.
    Sun, A. -H.
    Peng, X. -G.
    Zhang, X.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S486 - S487
  • [30] THERAPY OF ADVANCED ACUTE MYELOBLASTIC-LEUKEMIA WITH CYTARABINE AND INTERLEUKIN-2
    BUTTURINI, A
    BONILAURI, E
    IZZI, G
    CROCI, G
    FRANCHI, F
    SANTUCCI, MA
    TONDELLI, MT
    SCANDERBEG, AC
    [J]. LEUKEMIA RESEARCH, 1991, 15 (08) : 759 - 763
12345